Ocular Therapeutix, Inc. Insider Transactions
Ocular Therapeutix, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Dugel Pravin
Director, See Remarks |
Sell | 21,494 @ $12.04 | $258.79 K | 3,227,244 | 08/25/2025 | 08/27/2025 | |
|
Nayak Sanjay
Chief Strategy Officer |
Sell | 1,885 @ $12.04 | $22.70 K | 279,738 | 08/25/2025 | 08/27/2025 | |
|
Heier Jeffrey S.
Chief Scientific Officer |
Sell | 3,063 @ $12.04 | $36.88 K | 259,911 | 08/25/2025 | 08/27/2025 | |
|
Kaiser Peter
Chief Development Officer |
Sell | 3,011 @ $12.04 | $36.25 K | 204,093 | 08/25/2025 | 08/27/2025 | |
|
Waheed Nadia
Chief Medical Officer |
Sell | 13,861 @ $8.05 | $111.58 K | 206,805 | 06/02/2025 | 06/03/2025 | |
|
Nayak Sanjay
Chief Strategy Officer |
Sell | 1,862 @ $7.17 | $13.35 K | 281,623 | 05/23/2025 | 05/27/2025 | |
|
Heier Jeffrey S.
Chief Scientific Officer |
Sell | 3,024 @ $7.18 | $21.71 K | 262,974 | 05/23/2025 | 05/27/2025 | |
|
Dugel Pravin
Director, See Remarks |
Sell | 21,219 @ $7.18 | $152.35 K | 3,499,099 | 05/23/2025 | 05/27/2025 | |
|
Kaiser Peter
Chief Development Officer |
Sell | 2,974 @ $7.17 | $21.32 K | 207,104 | 05/23/2025 | 05/27/2025 | |
|
LINDSTROM RICHARD L MD
Director |
Buy | 10,000 @ $6.96 | $69.60 K | 172,704 | 05/08/2025 | 05/12/2025 | |
|
Nayak Sanjay
Chief Strategy Officer |
Sell | 1,895 @ $6.84 | $12.96 K | 283,485 | 02/24/2025 | 02/26/2025 | |
|
Kaiser Peter
Chief Development Officer |
Sell | 3,009 @ $6.87 | $20.67 K | 210,078 | 02/24/2025 | 02/26/2025 | |
|
Heier Jeffrey S.
Chief Scientific Officer |
Sell | 3,061 @ $6.87 | $21.03 K | 265,998 | 02/24/2025 | 02/26/2025 | |
|
Dugel Pravin
Director, See Remarks |
Sell | 21,475 @ $6.87 | $147.53 K | 3,520,318 | 02/24/2025 | 02/26/2025 | |
|
Notman Donald
See Remarks |
Sell | 11,119 @ $7.81 | $86.84 K | 193,444 | 02/04/2025 | 02/04/2025 | |
|
Notman Donald
See Remarks |
Sell | 6,301 @ $7.84 | $49.40 K | 204,563 | 01/31/2025 | 02/04/2025 | |
|
Dugel Pravin
Director, See Remarks |
Sell | 20,680 @ $9.01 | $186.33 K | 791,793 | 11/25/2024 | 11/27/2024 | |
|
Heier Jeffrey S.
Chief Scientific Officer |
Sell | 2,948 @ $9.01 | $26.56 K | 269,059 | 11/25/2024 | 11/27/2024 | |
|
Kaiser Peter
Chief Development Officer |
Sell | 2,897 @ $9.01 | $26.10 K | 213,087 | 11/25/2024 | 11/27/2024 | |
|
Nayak Sanjay
Chief Strategy Officer |
Sell | 1,814 @ $9.00 | $16.33 K | 174,380 | 11/25/2024 | 11/27/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ocular Therapeutix, Inc. FAQ's
The list of insiders at Ocular Therapeutix, Inc. includes Notman Donald, Dugel Pravin, Nayak Sanjay, Kaiser Peter, Heier Jeffrey S., LINDSTROM RICHARD L MD, Waheed Nadia.
Insiders have sold a total of 119.25 K Ocular Therapeutix, Inc. shares in the last 12 months for a total of 1.01 M sold.
The following insiders have sold Ocular Therapeutix, Inc. shares in the last 12 months: Notman Donald ($136.24 K), Dugel Pravin ($558.67 K), Nayak Sanjay ($49.01 K), Kaiser Peter ($78.25 K), Heier Jeffrey S. ($79.62 K), Waheed Nadia ($111.58 K),
Insiders have purchased a total of 10.00 K Ocular Therapeutix, Inc. shares in the last 12 months for a total of 69.60 K.
The following insiders have purchased Ocular Therapeutix, Inc. shares in the last 12 months: LINDSTROM RICHARD L MD ($69.60 K),